Dosing with recombinant factor VIIa based on current evidence

被引：40

作者：

Hedner, U ^{[1
]}

机构：

[1] Novo Nordisk AS, Res & Dev, DK-2760 Malov, Denmark

来源：

SEMINARS IN HEMATOLOGY | 2004年 / 41卷 / 01期

关键词：

D O I：

10.1053/j.seminhematol.2003.11.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：35 / 39

页数：5

共 40 条

[1] CONGENITAL SPCA DEFICIENCY - A HITHERTO UNRECOGNIZED COAGULATION DEFECT WITH HEMORRHAGE RECTIFIED BY SERUM AND SERUM FRACTIONS [J].

ALEXANDER, B ;

GOLDSTEIN, R ;

LANDWEHR, G ;

COOK, CD ;

ADDELSON, E ;

WILSON, C .

JOURNAL OF CLINICAL INVESTIGATION, 1951, 30 (06) :596-608

[2] The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation [J].

Allen, GA ;

Monroe, DM ;

Roberts, HR ;

Hoffman, M .

BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S3-S7

[3] Mechanism of factor VIIa-dependent coagulation in hemophilia blood [J].

Butenas, S ;

Brummel, KE ;

Branda, RF ;

Paradis, SG ;

Mann, KG .

BLOOD, 2002, 99 (03) :923-930

[4] Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures [J].

Cooper, HA ;

Jones, CP ;

Campion, E ;

Roberts, HR ;

Hedner, U .

HAEMOPHILIA, 2001, 7 (05) :517-522

[5]

FRIEDRICH U, 2003, 47 ANN M SOC THROMB

[6] EVALUATION OF A NEW CONCENTRATE FOR TREATMENT OF FACTOR 9 DEFICIENCY [J].

GILCHRIST, GS ;

EKERT, H ;

SHANBROM, E ;

HAMMOND, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (06) :291-+

[7]

Glazer S, 1995, ADV EXP MED BIOL, V386, P163

[8]

GRINGERI A, 1991, HAEMOSTASIS, V21, P1

[9]

Hay CRM, 1997, THROMB HAEMOSTASIS, V78, P1463

[10] The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX [J].

He, S ;

Blombäck, M ;

Ekman, GJ ;

Hedner, U .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) :1215-1219

← 1 2 3 4 →